Article Sidebar

pdf
Date Published: 09/02/2026
Abstract Views: 0
Views pdf: 0
DOI: https://doi.org/10.55046/vjrnm.61.1488.2025
Issue
No. 61 (2025)
Section
Medical Forum
How to Cite
Trần, L. M. C., Vo, T. D., Nguyen, Q. T. D., & Phan , C. C. (2025). Budd-Chiari Syndrome Role of Imaging Through A Case Serie. Vietnamese Journal of Radiology and Nuclear Medicine, 61, 66-72. https://doi.org/10.55046/vjrnm.61.1488.2025

Budd-Chiari Syndrome Role of Imaging Through A Case Serie

Lê Minh Châu Trần1, , Vo Tan Duc2, Nguyen Quang Thai Duong3, Phan Cong Chien3
1 Bệnh viện Đại học Y dược Tp Hồ Chí MInh
2 Department of Diagnostic Imaging, University of Medicine and Pharmacy of Ho Chi Minh City
3 Department of Diagnostic Imaging, University Medical Center of Ho Chi Minh City

Main Article Content

Abstract

Budd-Chiari syndrome is a rare entity caused by obstruction of the hepatic venous outflow. The obstruction can be located in the venules up to the inferior vena cava (IVC) into the right atrium. The causes of the disease are diverse and the distribution varies by geographical region. Depending on the cause, the progression, prognosis and treatment options will also be different. Therefore, we would like to introduce 3 clinical cases of Budd-Chiari syndrome caused by 3 different causes to illustrate the diversity of manifestations of this syndrome as well as the role of imaging in the diagnosis and management of this disease.

Keywords

Budd-Chiari syndrome, Cirrhosis, Portal hypertension

Article Details

References

1. Y. Li, V. De Stefano, H. Li. Epidemiology of Budd-Chiari syndrome: A systematic review and meta-analysis. Clinics and Research in Hepatology and Gastroenterology 2019 Vol. 43 Issue 4 Pages 468-474. DOI: https://doi. org/10.1016/j.clinre.2018.10.014
2. M. Pellone, A. Zanetto and M. Senzolo. History of Budd–Chiari Syndrome. Springer Singapore 2020. DOI 10.1007/978-981-32-9232-1_1
3. A. Mancuso. Budd-Chiari Syndrome Management: Controversies and Open Issues. Diagnostics (Basel) 2022 Vol. 12 Issue 11. DOI: 10.3390/diagnostics12112670
4. G. Mukhiya, X. Zhou, X. Han. Evaluation of outcome from endovascular therapy for Budd-Chiari syndrome: a systematic review and meta-analysis. Sci Rep 2022 Vol. 12 Issue 1 Pages 16166. DOI: 10.1038/s41598-022-20399-x
5. A. Shukla, A. Shreshtha, A. Mukund. Budd-Chiari syndrome: consensus guidance of the Asian Pacific Association for the study of the liver (APASL). Hepatol Int 2021 Vol. 15 Issue 3 Pages 531-567. DOI: 10.1007/s12072-021- 10189-4
6. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Vascular diseases of the liver. J Hepatol 2016 Vol. 64 Issue 1 Pages 179-202. DOI: 10.1016/j.jhep.2015.07.040
7. V. Bansal, P. Gupta, S. Sinha. Budd-Chiari syndrome: imaging review. Br J Radiol 2018 Vol. 91 Issue 1092 Pages 20180441.
8. R. X. Song, S. F. Cai, S. Ma, Z. L. Magnetic Resonance Venography Findings of Obstructed Hepatic Veins and the Inferior Vena Cava in Patients with Budd-Chiari Syndrome. Korean J Radiol 2018 Vol. 19 Issue 3 Pages 381-388. DOI: 10.3348/kjr.2018.19.3.381
9. P.-X. Ding and E. W. Lee. Spontaneous Portosystemic Shunt with Budd-Chiari Syndrome. Radiology 2021 Vol. 301 Issue 2 Pages 282-282. DOI: 10.1148/radiol.2021210691
10. M. Van Wettere, L. Paulatto, L. Raynaud. Hepatobiliary MR contrast agents are useful to diagnose hepatocellular carcinoma in patients with Budd-Chiari syndrome. JHEP Rep 2020 Vol. 2 Issue 3 Pages 100097. DOI: 10.1016/j. jhepr.2020.100097
11. C. J. Das, M. Soneja, S. Tayal. Role of radiological imaging and interventions in management of Budd-Chiari syndrome. Clin Radiol 2018 Vol. 73 Issue 7 Pages 610-624. DOI: 10.1016/j.crad.2018.02.003